The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...

The Galien Foundation, a global institution committed to recognizing collaborative scientific and medical innovations that advance patient care, celebrated the inaugural Prix Galien Bridges Awards on ...

Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorablesafety ...

DelveInsight's Acute on Chronic Liver Failure Market Insights report includes a comprehensive understanding of current treatment practices, acute on chronic liver failure emerging drugs, market share ...

Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cycles ...

The centre has opened up innovative financing to industries through a layered RDI fund. The fund is aimed to accelerate the ...

Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall response rate(ORR) in this subgroup of patients; 80% ORR ...